SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-027555
Filing Date
2021-05-13
Accepted
2021-05-13 16:15:38
Documents
62
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ikna-10q_20210331.htm 10-Q 1799547
2 EX-31.1 ikna-ex311_9.htm EX-31.1 19069
3 EX-31.2 ikna-ex312_8.htm EX-31.2 19196
4 EX-32.1 ikna-ex321_6.htm EX-32.1 16119
  Complete submission text file 0001564590-21-027555.txt   4891546

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ikna-20210331.xml EX-101.INS 713122
6 XBRL TAXONOMY EXTENSION SCHEMA ikna-20210331.xsd EX-101.SCH 44541
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ikna-20210331_cal.xml EX-101.CAL 35445
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ikna-20210331_def.xml EX-101.DEF 104774
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ikna-20210331_lab.xml EX-101.LAB 327139
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ikna-20210331_pre.xml EX-101.PRE 243084
Mailing Address 50 NORTHERN AVE. BOSTON MA 02210
Business Address 50 NORTHERN AVE. BOSTON MA 02210 857-343-8292
Ikena Oncology, Inc. (Filer) CIK: 0001835579 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40287 | Film No.: 21919826
SIC: 2836 Biological Products, (No Diagnostic Substances)